Ever wondered about world leading career opportunities in County Donegal? Do you want a rewarding and challenging career in the global Life Sciences industry matched with an equally high quality of life?
Randox Teoranta are building a workforce of 540 in Dungloe, operating from the modernised facilities in Meenmore, Dungloe.
The plans call for a total of 180 research scientists and engineers, 270 high quality manufacturing operatives and 90 support staff, all of whom will be able to call the breathtaking beauty of County Donegal their home.
With this expansion in mind, opportunities now exist for life scientists, conducting R&D into a wide range of clinical conditions, Electrical and Mechanical Engineers and Software Engineers to develop and support the pioneering analysers and diagnostics tests that make Randox Laboratories a world leader in the diagnostic market.
If you want to develop a world-class career, improving and saving lives through cutting-edge biotechnology that is no less awe-inspiring than the breath-taking natural surroundings of Donegal – drop in to our informal Christmas Eve Open Morning to find out more.
Dr. Peter FitzGerald, Managing Director of Randox Laboratories, and the visionary behind this expansion, commented;
“Randox are committed to expanding our operations in Dungloe and see the diaspora networks as key to our success. As well as employing locally, we want to draw top class talent back to Donegal from the great Irish diaspora. We can offer great careers to the right people, combined with the wonderful Co. Donegal lifestyle.”
Career opportunities are available now in Randox Teoranta, Dungloe, for:
• Graduates in life sciences; mechanical, electrical and embedded engineering; software testing; and software development.
• Those with industrial experience within life sciences; diagnostics; medical device engineering; and software development.
On our Christmas Eve Open Morning you will have the opportunity to meet with current Randox Teoranta members of staff, take a tour of our ultra-modern facilities and ask all the questions you’ve ever wanted to know about Randox Teoranta.
Randox Teoranta Christmas Eve Open Morning
9a.m. – 11.30a.m.
Address: Randox Teoranta, Meenmore, Dungloe, Co. Donegal.
Tel: +353 7495 22600
Randox Laboratories is representing our ever-growing knowledge economy this week at the world’s largest medical exhibition, the Medica World Forum for Medicine International Trade Fair.
Randox is joining a host of other healthcare exhibitors from over 120 countries, on over 1.3million square feet of exhibition space at the Düsseldorf Fairgrounds in Germany. The event, which runs for four days between Monday and Thursday, will showcase the latest developments across a range of medical sectors including Laboratory Equipment, Diagnostics, Physiotherapy and Orthopedic Technology, Communication and Information Technology, and Medical Services and Publications.
The Medica Trade Fair provides Randox and over 4800 other exhibitors the opportunity to showcase new and existing diagnostic capabilities to the world. With key manufacturing sites in Co. Antrim and Co. Donegal, in India and just outside Washington DC, Randox Laboratories diagnostics are already used and trusted by medical professionals across the globe, and are also available to the general public at Randox Health Clinics in Northern Ireland and in London.
Exporting to 145 countries, and with more tests in development than any other diagnostics company, Randox is a leading innovator in the fight against illnesses such as cancer, coronary heart disease and diabetes, and is dedicated to saving and improving lives around the globe through preventative healthcare and early diagnosis.
At the Medica Fair, 30 members of the Randox team, including Senior Managers and Expert Scientists from a range of disciplines, will showcase to over 130,000 visitors a range of novel diagnostic tests for conditions such as diabetes, aspirin resistance, cardiovascular risk and gastric problems – highlighting just how our home-grown scientists are benefiting lives across the globe.
John Lamont, Chief Scientist at Randox Laboratories, commented:
“As a firmly established event in the medical calendar, The Medica Fair is the perfect opportunity for Randox to display to the global healthcare industry how our world-class diagnostics make a difference in the lives of so many patients across the world. From routine cholesterol checks to complex tests used in diagnosis of respiratory conditions, Randox is working behind the scenes from the moment you provide a blood sample to your GP.
In addition to our range of current extensive capabilities, we are also excited to share some new tests for aspirin resistance, cardiovascular risk and gastric problems at the Medica Fair, the hub of the medical trade. Randox is at the forefront of life-changing research and development in the medical industry and we are proud that we can show the Medica audience how our innovative diagnostic tests are paving the way for the future of healthcare.”
The Medica World Forum for Medicine International Trade Fair runs from Monday 16th to Thursday 19th November, and Randox will be in Hall 3 at Stand A08.
Donegal will be promoted as a world-class place to live and do business, at a leading Irish-American event in Boston this week.
The annual conference of Irish Networks USA, which connects Irish associations in cities across the US in order to bolster business, cultural, and community links between the United States and Ireland, is taking place between 5th and 8th November.
Irish and Irish-American professionals living across the US will attend the event, to engage with the Irish diaspora and with key envoys from Irish businesses. Supported by the Department of Foreign Affairs and Trade of Ireland, those attending will have the opportunity to hear from speakers including the Irish Ambassador to the United States, Anne Anderson, and Mark Redmond, Chief Executive of the American Chamber of Commerce Ireland.
Additional backing for the event comes from Tourism Ireland and leading Donegal-based company, Randox Laboratories, which boasts facilities in Dungloe, as well as Co. Antrim and the Greater Washington DC area. Through reaching out to the Irish diaspora in the US, the company plans to promote the growing economy in Donegal through the creation of hundreds of new jobs over the next few years, as well as promote opportunities at the US facility near Washington DC.
The event kicks off on Thursday evening with a welcome gathering for those who have travelled to Boston from across the US, before the conference begins on Friday 6th November, where attendees will engage on a range of topics including global education, transatlantic business links, and the global Irish diaspora network. Delegates are then invited to celebrate the fifth anniversary of Irish Network Boston at the historic venue of Massachusetts Old State House.
Mark Campbell, Senior Manager at Randox Laboratories, is speaking at the conference:
“We are delighted to promote Donegal as a world-class destination for life-science professionals. Working with the diaspora network, we can get the message out there that Donegal has exciting career opportunities, great community networks and strong infrastructure, proving it to be a highly desirable place to work and live.
Additionally, as Randox expands its operations in the US, we are keen to promote our facility in the Greater Washington DC area where there will be increasing job opportunities over the next few months.”
Are you The One for Randox?
That’s the question Randox Careers are asking first year students this week, with the launch of an innovative new recruitment campaign for their competitive APEX Programme, which employs first year undergraduates across various divisions of the global diagnostics company.
The campaign, named #IAmTheOneUU, which begins this week with a number of recruitment presentations in Ulster University, is taking a fresh approach to the way first years can apply for the APEX Programme, by inviting applicants to submit ‘video auditions’ on social media platforms Facebook, Instagram and Twitter. Using a video no longer than 15 seconds and a 140 character cover note, the aim of this unique method of application is to give first year university students the opportunity to succinctly and effectively convey their personality, creativity, initiative and drive, in a lively and imaginative way; displaying why they are ‘The One’ for Randox.
Successful APEX applicants from Ulster University will progress throughout Randox over the course of four years; moving from a summer of paid full-time work experience, to a paid placement year within the company, to ultimately obtaining a full time position at Randox, subject to gaining a 2:1 or above.
The importance of this opportunity cannot be underestimated; with many students having difficulty finding jobs after graduation, the APEX Programme will help 50+ students this year really get their foot on the career ladder, and build relationships with a thriving market leader in the healthcare industry.
Linda Magee, Randox Human Resources Manager, is excited to launch such a novel campaign that resonates so well with first year students;
“The #IAmTheOneUU application process for the Randox APEX Programme is a fresh and dynamic campaign that utilizes the power of social media and harnesses the skills of the tech-savvy generation. Young people of this age are well-acquainted with the likes of Facebook, Twitter and Instagram and by using their social media capabilities to display their personality and ambition, they can successfully achieve their career goals in positions ranging from Business and Marketing to Biological and Life Sciences, Graphic Design to Mathematics and Physics, and Engineering to Computer Technology. For busy first years this exciting yet simple method of application is the perfect way for them to introduce themselves to Randox. Get posting – you could be The One!”
Any first year undergraduates at Ulster University who wish to join the Randox APEX Programme should upload a 15 second video with accompanying 140 character note to either Twitter, Facebook or Instagram, making sure to include the hashtag #IAmTheOneUU.
Visit Iamtheone.randox.com for more information.
As global sponsor of Camerata Ireland, Randox will be taking to the world’s stage with the all-Ireland orchestra in South America this week, as the Chamber Orchestra begins their South American tour tonight in Buenos Aires.
World-renowned pianist and conductor Barry Douglas and his orchestra of talented musicians, whose joint patrons are Michael D Higgins, President of Ireland and Queen Elizabeth II, have made the long journey from Ireland to Argentina for tonight’s performance, to display the rich Irish musical heritage to South American audiences.
The tour, which begins this evening in the renowned Teatro Coliseo in Buenos Aires will see the all-Ireland orchestra perform a diverse tapestry of classical music, led by Camerata Ireland founder and 1986 Tchaikovsky International Piano Competition Winner Barry Douglas, and supported by distinguished flautist Eimear McGeown, who has established a busy and varied musical career since winning Camerata Young Musician of the Year in 2006.
Tomorrow night the orchestra will remain in Argentina for a performance at the Teatro El Círculo Laprida in Rosario and on Friday night will capture the audience of the Teatro del Libertador in Córdoba, and finally head to Santiago de Chile for the final installment of their South American tour in the Teatro CorpArtes. Barry and Eimear are also performing at a special event at the British Consulate in São Paulo in Brazil.
Barry Douglas, Creator and Artistic Director of Camerata Ireland said;
“We are all thrilled to be here in South America for our tour across the continent – there is nothing quite like music in its ability to connect with cultures across the globe. Music as a universal language can be understood and appreciated by anyone, and we are excited to be able to convey an image of Ireland to audiences across South America, through our performances. We are equally delighted that we can share this experience with Randox Laboratories, who continue to help the growth and development of our orchestra, and we couldn’t have achieved our internationally-acclaimed reputation without them.”
Dr. Peter FitzGerald, Managing Director at Randox Laboratories said;
“It is not surprising that at Randox we truly value our partnership with Camerata Ireland, given that both organisations rely on the same values of passion and enthusiasm for their international success. On behalf of everyone here at Randox I would like to wish Camerata Ireland all the best with their South America tour. We are delighted that Barry Douglas and his orchestra continue to showcase our Irish musical talent across the globe, and it brings us great joy knowing that Randox can simultaneously support our young Irish musicians in their careers while also strengthening key business relationships and promoting exports.”
Camerata Ireland will perform tonight the 21st October in Buenos Aires, in Rosario on the 22nd October, in Cordoba the 23rd October, at The British Consulate in São Paulo on the 28th, and will also perform two events in Santiago de Chile on the 29th and 30th October.
Representatives from business, community and political life in northwest Ireland travelled to Boston this week to take part in the seventh annual Golden Bridges conference promoting transatlantic partnerships.
Among key Irish American speakers at the two day gathering (21-22 October 2015) are Mayor Marty Walsh of Boston and Marty Meehan, President of the University of Massachusetts.
Backed by Councils from Donegal, Derry City, and Strabane, the event in the Seaport Hotel, Boston, will hear from Donegal County Council Chairperson, Councillor Ciarán Brogan, and Maiden City Mayor, Councillor Elisha McCallion.
Key backing for the transatlantic initiative has come from Invest Northern Ireland in the US with two companies which have made recent investments in Derry-Londonderry, OVS and Metaverse Mod Squad, being honoured at a gala luncheon during the conference.
The event in Boston will focus on a life sciences forum on linking Boston and North West Ireland’s changing life sciences industries. Speakers will include bio-entrepreneur Susan Whoriskey and Mark Campbell, Senior Manager at Randox Laboratories which boasts facilities in Co. Antrim, Co. Donegal and in the US. Mark will also be speaking at Harvard University on the potential of Irish life science innovations to improve healthcare globally. Commenting on the event, Mark said:
“This is a great opportunity to strengthen life science links between the North West of Ireland and Boston. We at Randox know that we have much to offer and we’re very grateful for the support from Donegal County Council and Údarás na Gaeltachta in enabling this event to happen.”
For more details: aisling-events.com
A ground-breaking undercover investigation has exposed the deadly world of legal highs, the latest drug craze sweeping the UK and causing devastation to families and communities across the country.
An investigative team from the BBC followed the journey of these dangerous and highly addictive substances from source to sale and used secret filming to reveal that legal substances bought in the UK’s high streets pose a hazardous and lethal risk.
During the hour-long programme this evening on BBC Scotland, journalists shine a spotlight on the growing legal high epidemic, where synthetic drugs are designed to mimic the effects of illegal drugs such as cannabis, ecstasy and cocaine.
The team enlisted the help of Randox Testing Services, to further investigate the make-up of these drugs, which contain a cocktail of chemical ingredients that suppliers continually tweak to evade the law.
But the legality of these ‘highs’ in no way makes the drugs any safer. The disturbing test results show that legal highs bought in the UK contain a poisonous mixture of synthetic cannabinoids which have as strong an effect as illegal drugs, such as LSD or Amphetamines, and in some cases even stronger.
Sadly, the statistics correspond, as Government figures show that in just three short years the number of deaths in the UK linked to legal highs grew from 12 in 2009, to 97 in 2012.
It is a growing problem that Dr. Mark Piper, Head of Toxicology at Randox Testing Services, is all too familiar with:
“It’s very much back-room and underground chemistry that’s behind all this. You don’t know what’s in them and what quantities of chemicals are used, and therefore how much to take. These substances were not even designed to be used on humans, so in taking them you are playing Russian roulette with your life.”
Piper added; “In supporting the fantastic investigative team from the BBC we are glad to assist in highlighting this growing epidemic which has had shattering effects on families and communities across the UK.”
The intense rise in prevalence of legal highs and their catastrophic effects has sparked the debate of a controversial Psychoactive Substances Bill, which potentially will implement a blanket ban on the production, distribution, sale and supply of any substance defined as having a ‘psychoactive effect’.
This BBC Scotland documentary will air tonight, Monday, 5th October 2015, on BBC One Scotland at 9p.m.
Global biotechnology firm Randox, has invested more than £400,000 in upgrading the telecoms infrastructure near its headquarters in Crumlin, County Antrim. As a result, a number of businesses and residents in Northern Ireland will have access to previously unavailable fibre-optic broadband. The upgrade, essential to supporting Randox’s growing IT requirements, has involved laying down 12 kilometres of fibre-optic cable, stretching from Nutts Corner to the Lough Neagh shoreline.
The telecoms project is part of a wider investment in software, telecoms and data processing by the medical diagnostics company, as IT Manager Stephen Fawl explains:
“Randox is an international company, dealing with customers in more than 145 countries, and as such we need a world class communications network. This new fibreoptic broadband gives us the capacity, security and speed that we need. The new network extending from Nutts Corner to Randox headquarters runs at a hefty 20 gigabytes…That is enough capacity for 15 business parks or a quarter of a million homes.”
Thomas Burns, SDLP Councillor for Aldergrove and Crumlin is encouraging local residents and business owners to take advantage of the improved connectivity:
“The investment by Randox, means that anyone in proximity to the new cable can tap into the highest broadband speeds available. Businesses, especially those depending on electronic orders and skype communications can now expect the same speed and security of internet enjoyed by those in Belfast. Residents in the area can also upgrade through their broadband provider. Before this upgrade project, much of the surrounding area was a telecoms dead zone; but now this is a win-win situation with a significant boost for the local community.”
Residents and business owners in the Crumlin area keen to upgrade to high-speed fibre-optic broadband should contact their internet service provider to discuss various upgrade bundles.
Global biotechnology firm, Randox Laboratories, is taking a leading role in the world’s largest medical conference which is currently under way in Atlanta, Georgia.
The Northern Ireland medical diagnostics company is a major sponsor of the American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo, which is attended by over 20,000 delegates and 784 exhibitors from across the globe.
As the leading event for laboratory medicine worldwide, the conference provides an opportunity for breakthrough innovations in clinical testing and patient care to be introduced to the healthcare world.
A group of 32 members of Randox staff are attending the event, exhibiting Randox’s wide range of products and capabilities, which are exported to 145 countries. AACC provides a valuable opportunity to develop new business and clinical partnerships, as well as to consolidate and strengthen current relationships.
Managing Director of Randox, Dr. Peter FitzGerald, is attending the conference and says that the company is proud to be promoting Northern Ireland business to an international audience:
“The global laboratory diagnostics market, is currently valued at around US$55 billion, and is growing at 5.3% per year. With ambitious plans for growth over the next few years, we are committed to improving healthcare worldwide through our investment in our people and the world’s most revolutionary diagnostic technology. Our presence at the AACC annual meeting is fundamental to achieving our strategic aims in promoting our brand, and in strengthening Northern Ireland trade links across the world.”
AACC runs from the 28th – 30th July at the Georgia World Congress Center in Atlanta, Georgia.
- £15 million invested in R&D 2014-15
- Funding allows creation of bold new division – Randox Biosciences
- Job creation – 30 new staff
- International focus – Japan, USA, Europe; key markets
Global biotechnology firm Randox, is unveiling its latest enterprise, ‘Randox Biosciences’. The new specialist division within Randox, is dedicated to advancing scientific discovery, drug development and companion diagnostics. Randox Biosciences is the result of the merger and expansion of four existing business units; Life Sciences, Pharma Sciences, Research and Molecular.
15 new jobs have already been created at the unit based in Crumlin, with that figure expected to double by the end of the year. A core team of over 300 R&D scientists and engineers are employed at the Randox Biosciences hub, specialising in supplying products and services to universities, genetics labs and the pharmaceutical industry across the globe.
Exports and international collaborations will be key drivers of growth for the new division, as Patrick Henry, Head of Randox Biosciences explains:
“Our focus is on targeting the thriving personalised medicine market which at its heart relies on ‘precision medicine’ enabling technology and tests to tailor healthcare solutions to the right patients at the right time. Led by our dedicated research scientists, we offer advanced products, for use in academic research enabling new scientific discoveries and in pharma companies for their drug development and clinical trials.
“A particularly exciting area for Randox Biosciences is in Companion Diagnostic development. This is where new diagnostic tests are developed and approved alongside new drugs improving their efficacy and safety, whilst helping to reduce costs for healthcare networks by avoiding unnecessary or ineffective drug prescriptions.
“Precision medicine is next generation health care, with huge potential for Randox in terms of exports and collaborations. We are already creating traction in the US and Europe and have our sights set on Japan, in which we expect to have a solid presence by Autumn.”
Funding for the Randox Biosciences division is as a result of the Randox group’s commitment to innovative R&D says Randox MD, Dr Peter FitzGerald:
“Research and development is fundamental to the creation of new products and we recognise its importance. In 2014-15 we invested £15million into R&D, our most significant spend on this core function to date. This investment has allowed us to establish the Randox Biosciences division, which will act as a road map for our R&D, taking our tests and technology to new markets across the world.
“At the moment, Randox Biosciences is engaged in world-leading research into Alzheimer’s disease and cancer and is involved in more than 35 collaborations with internationally renowned academic research centres. The Randox Biosciences team is truly at the frontier of health care discovery, making our vision a reality.”